PATHOGENIC MECHANISMS IN MYASTHENIA GRAVIS
重症肌无力的致病机制
基本信息
- 批准号:3399860
- 负责人:
- 金额:$ 19.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1984
- 资助国家:美国
- 起止时间:1984-07-01 至 1991-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
(Adapted from the applicant's abstract) The goal of this project is to
determine the pathogenic mechanisms by which the autoantibodies in MG
induce abnormal neuromuscular transmission and to devise means of blocking
such effects. It is suggested that these studies would provide a
groundwork for the development of antigen-specific treatments of this and
other antibody-mediated autoimmune disorders. pEAMG induced by
administration of monoclonal antibodies (mAbs) directed against the AChR
in normal rates provides the experimental rationale for these studies.
The hypothesis to be tested is that the major pathogenic mechanism in MG
is complement-mediated damage to the AChR-containing post-synaptic
membrane initiated by complement activation by bound anti-AChR Abs. Abs,
whose complement activating capacity has been modified (F(ab')2),
fragments of mAbs, and genetically engineered hybrid Abs with little of no
complement activating activity will be produced and used in these studies.
The engineered Abs are to be produced by myeloma cells transfected with
recombinant genes which encode V regions from disease-inducing anti-AChR
mAbs and constant regions which lack complement activating activity. The
ability of the modified or engineered Abs to induce pEAMG or block EAMG
induced by intact Abs will be assessed clinically, morphologically,
electrophysiologically and by chemical and autoradiographic analysis of
AChR content at muscle end plates.
(改编自申请人的摘要)这个项目的目标是
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID P RICHMAN其他文献
DAVID P RICHMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID P RICHMAN', 18)}}的其他基金
Development of Animal Models of Anti-MuSK Myasthenia
抗MuSK肌无力动物模型的建立
- 批准号:
8048710 - 财政年份:2010
- 资助金额:
$ 19.04万 - 项目类别:
Development of Animal Models of Anti-MuSK Myasthenia
抗MuSK肌无力动物模型的建立
- 批准号:
8152160 - 财政年份:2010
- 资助金额:
$ 19.04万 - 项目类别:
IX INTERNATIONAL CONFERENCE ON MYASTHENIA GRAVIS
第九届重症肌无力国际会议
- 批准号:
2038867 - 财政年份:1997
- 资助金额:
$ 19.04万 - 项目类别:
STRUCTURE/FUNCTION ANALYSIS OF ACCHR EPITOPES
ACCHR 表位的结构/功能分析
- 批准号:
3100129 - 财政年份:1987
- 资助金额:
$ 19.04万 - 项目类别:
STRUCTURE/FUNCTION ANALYSIS OF ACCHR EPITOPES
ACCHR 表位的结构/功能分析
- 批准号:
3100128 - 财政年份:1987
- 资助金额:
$ 19.04万 - 项目类别:
STRUCTURE/FUNCTION ANALYSIS OF ACCHR EPITOPES
ACCHR 表位的结构/功能分析
- 批准号:
3100131 - 财政年份:1987
- 资助金额:
$ 19.04万 - 项目类别:
STRUCTURE/FUNCTION ANALYSIS OF ACCHR EPITOPES
ACCHR 表位的结构/功能分析
- 批准号:
3100126 - 财政年份:1987
- 资助金额:
$ 19.04万 - 项目类别:
STRUCTURE/FUNCTION ANALYSIS OF ACCHR EPITOPES
ACCHR 表位的结构/功能分析
- 批准号:
3100130 - 财政年份:1987
- 资助金额:
$ 19.04万 - 项目类别:
相似海外基金
Autoimmune disorder in hereditary angioedema
遗传性血管性水肿中的自身免疫性疾病
- 批准号:
26460654 - 财政年份:2014
- 资助金额:
$ 19.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanisms of lymphocyte transmigration across the blood-brain barrier using an in vitro model that mimics blood flow and simulates inflammatory conditions as observed in the most frequent autoimmune disorder of the central nervous system, multiple sclero
使用体外模型模拟血流并模拟在中枢神经系统最常见的自身免疫性疾病多发性硬化症中观察到的炎症状况,从而研究淋巴细胞跨血脑屏障的迁移机制
- 批准号:
235301825 - 财政年份:2013
- 资助金额:
$ 19.04万 - 项目类别:
Research Fellowships
The challenge for the development of therapy for autoimmune disorder by the establishment of artificial thymic medullary organ
人工胸腺髓质器官的建立对自身免疫性疾病治疗发展的挑战
- 批准号:
23659241 - 财政年份:2011
- 资助金额:
$ 19.04万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research